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Abstract
The transition from traditional culture methods towards bioreactor based bioprocessing to produce cells in commercially
viable quantities for cell therapy applications requires the development of robust methods to ensure the quality of the cells
produced. Standard methods for measuring cell quality parameters such as viability provide only limited information
making process monitoring and optimisation difficult. Here we describe a 3D image-based approach to develop cell
distribution maps which can be used to simultaneously measure the number, confluency and morphology of cells attached
to microcarriers in a stirred tank bioreactor. The accuracy of the cell distribution measurements is validated using in silico
modelling of synthetic image datasets and is shown to have an accuracy .90%. Using the cell distribution mapping process
and principal component analysis we show how cell growth can be quantitatively monitored over a 13 day bioreactor
culture period and how changes to manufacture processes such as initial cell seeding density can significantly influence cell
morphology and the rate at which cells are produced. Taken together, these results demonstrate how image-based analysis
can be incorporated in cell quality control processes facilitating the transition towards bioreactor based manufacture for
clinical grade cells.
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Introduction
The use of living cells in clinical applications offers great benefits
over traditional treatments potentially allowing damaged and
diseased tissues to be repaired rather than replaced. However,
producing cells in the quantities required for cell based therapies
presents many challenges, particularly as the cells often have to be
adhered to a substrate, limiting the numbers of cells that can be
produced using standard cell culture practices. This is driving the
need for the development of new culture processes which not only
have the robustness of traditional methods but are also efficient
and scalable enough to produce cells in the amounts required for
therapeutic application [1].
A promising approach for producing large numbers of cells is
the use of bioreactors. These systems have been used extensively
within the bioprocessing industry for many years to grow
suspension cells for the manufacture of high value biochemicals
(e.g. antibody production by hybridoma cells) [2] but are now
increasingly being applied for the production of cells which require
anchorage to a substrate in order to grow. One of the most
commonly applied approaches is to use cells adhered to the surface
of three dimensional (3D) microcarriers in a stirred tank bioreactor
[3]. This approach provides a large surface area for cell
production, due to the surface area of the microcarriers, while
the stirring provides a homogenous culture environment, facili-
tating mass transfer of nutrients to all cells [4] thereby achieving
higher cell yields than conventional (2D) culture methods. Scaling
production of cells, using different microcarrier systems in stirred
tank bioreactors, has been shown, under optimal conditions, to
increase the yield of cells by as much as 12 fold when compared
with traditional culture methods [5] and has been applied to a
range of cell therapy models including mesenchymal stem cells
[6,7], embryonic stem cells [5,8], fibroblasts [9] and keratinocytes
[10]. Despite these proof of concept reports, bioreactor based cell
production is still mostly performed at the pilot scale (up to 1 litre
volume) and in-process monitoring of the cells is usually limited.
Measuring cell growth and assessing cell quality in standard
culture is usually achieved using simple imaging techniques such as
brightfield microscopy which can be used to monitor several
parameters simultaneously. Cell morphology, viability and prolif-
eration, which are good indicators of cell health, can be monitored
pro re nata to ensure quality, while cell number and confluency (the
percentage of the growth surface covered by cells) can be used to
judge the optimal point at which to retrieve cells from culture in
order to maximise cell yields. In bioreactor cultures these
multiparametric measurements are more complicated due to the
fact that the cells are adhered onto a 3D growth substrate and as
such most reports on the growth of cells in bioreactors rely on a
single measure of cell number using either direct or indirect
measurements (Table 1). Direct measurements [8,11–26] require
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e26104
rthe cells to be removed enzymatically from the growth substrate
and stained using cell viability dyes for bright field (trypan blue
exclusion assay) or fluorescence microscopy (live/dead assays,
Hoechst for nuclear labelling). These methods provide the most
quantitative results, but the requirement for cells to be detached
from the substrate affects both cell number and viability and means
that important information about cell confluency and morphology
are lost. Indirect monitoring techniques [2,3,8,12,13,23–33] do not
require the cells to be removed from the growth substrate and
instead estimate cell growth based on parameters such as the
depletion of nutrients by the cells from the culture medium (an
indication of cell metabolism rates) or cell number based on the
enzymatic metabolism of compounds within the cells. For example,
the MTT assay which estimates cell number based on the reduction
of tetrazolium salts to formazan in the mitochondria. These
methods, while easier to perform, are less sensitive than direct
methods and provide no information on cell quality characteristics
such as morphology and confluency.
Ideally, a system is required for direct measurement of cell
number and viability in cells that remain attached to the 3D
growth substrate so that these measurements can be combined
with information on cell morphology and confluency, allowing
multiparametric analysis. To make these measurements quantita-
tive, this would require a system which allows the simultaneous
measurement of thousands of individual cells attached to hundreds
of microcarrier beads. An approach which could be used to
generate this information is 3D imaging, although the lack of
speed with which the image data sets can be acquired, processed
and analysed in the 3D volume may be prohibitive. In this paper
we investigate a novel approach to processing 3D image data to
create 2D cell distribution maps which can be used for rapid direct
analysis of the number, confluency and morphology of cells
adhered to the surface of microcarrier beads. This approach which
is validated using in silico modelling is applied to an exemplar
model system of human dermal fibroblast cells grown in a stirred
tank bioreactor to demonstrate its use for monitoring proliferation
and the health of cells under different manufacture conditions.
Materials and Methods
Standard cell culture
Cultures of Human dermal fibroblasts (HDF) (LGC Standards,
UK) were prepared by growing the cells adhered to T-175 cell
culture flasks (Corning, UK) in Dulbecco’s Modified Eagle
Medium containing 10% fetal bovine serum (DMEM), buffered
at pH 7.4 using 30 mM HEPES. Cells were maintained at 37uCi n
a humidified atmosphere with media changes every 48–72 hours
until ready for use. Cells from passage 12 to 17 were used for all
experiments.
Bioreactor cultures
Approximately 6.45610
6 Cytodex 1 microcarrier beads (GE
Healthcare, UK) were prepared by washing 3 times in phosphate
buffered saline (PBS) solution for 4 h and sterilised in 70% ethanol
overnight. The beads were rinsed 3 times in PBS, re-suspended in
DMEM and placed into a 125 ml glass stirred tank bioreactor
(Corning,UK). HDF cells wereenzymaticallydissociated fromtheir
culture flasks by incubating the cells for 5 min with 0.025%
Trypsin-EDTA and resuspended in an equal volume of DMEM.
Cell number and viability were measured using the trypan-blue
assay. The HDF cells were seeded onto microcarriers by mixing
cells and microcarriers at a ratio of 5:1 or 10:1 in the stirred tank
bioreactor. Cells were allowed to attach to the microcarriers for
24 hours with 1 min 45 sec intermittent stirring at 40 RPM every
45 min. After 24 hours the stirring regime was changed to 2 min
intermittent stirring every 20 min for the remainder of the culture
process. DMEM growth media was replenished every 48–72 hours
by replacing 60% of the media.
Fluorescent labelling of live and dead cells
5 ml samples of DMEM media containing cells and micro-
carriers were removed from the stirred tank bioreactors under
sterile conditions at specific time points over a period of 13 days.
The microcarriers in each sample were allowed to settle by gravity.
Once settlement was complete the supernatant was removed and
the microcarriers were re-suspended in 1 ml of fresh DMEM
culture medium containing 4 mM calcein-AM (to label live cells)
and 2 mM ethidium homodimer-1 (to label dead cells) (Invitrogen,
UK) and incubated at 37uC for 30 min.
Laser scanning confocal microscopy
Fluorescently labelled cell samples were imaged using a Nikon
Eclipse TE2000 inverted laser scanning confocal microscope.
Images were acquired using the EZ-C1 acquisition and operating
software. Low magnification images were acquired at 610
magnification. A minimum of 10 fields of view comprising 15–30
microcarriers each were imaged for each time point. Z-interval was
set to a constant increment of 2.5 mm between successive focal
planes. An average of 100 images was collected per field of view,
encompassing the entire microcarrier volume. Live cells were
imaged at 488 nm excitation wavelength, dead cells at 543 nm.
Laser power was kept constant between each imaging session.
Development of cell distribution maps
Confocal images were processed using Matlab (R2008b, The
MathWorks, USA) for automatic detection of microcarriers,mapping
of live cell distribution around microcarriers, and quantification of
Table 1. Measurement techniques used to monitor the
quality of adherent cells in bioreactor culture.
Measurement
Technique
Culture
system References
Direct Trypan Blue Microcarriers 8, 11, 13–15, 17–19
Visualisation Aggregates 12, 16, 20
Fluorescent markers Microcarriers 17, 21
3D Scaffold 22
Nuclear counting Microcarriers 8, 13, 21–24
Aggregates 24
Light/Electron microscopy Microcarriers 17
Aggregates 25
Alamar Blue Microcarriers 26
Flow cytometry Microcarriers 17
Indirect Nutrient/Metabolites Microcarriers 8, 13, 23–28, 31
Metabolism Aggregates 2, 12, 28–30
Silk Scaffold 32
Cytosolic enzymes Microcarriers 3, 23–26
Aggregates 12, 24
MTT Microcarriers 13, 26, 33
Total DNA Aggregates 12
Silk Scaffold 32
doi:10.1371/journal.pone.0026104.t001
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the top maximum projection image to identify microcarrier positions
and radii in the 2D X-Y plane. A sub-volume encompassing each
microcarrier was extracted and further processed along the Z-axis in
order to identify top and bottom coordinates of the microcarrier. A
grid with resolution finer than the original images was mapped onto
the surface of a virtual sphere centred on the microcarrier to prevent
information loss from sub-optimal sampling. Fluorescence intensity
was iteratively sampled 30 times along the coordinates of this
spherical grid in the vicinity of the microcarrier surface, measuring
fluorescencealongorthogonal lines to the microcarrier surface, below,
at and above this surface. The process generated a 5006500630
matrix Mx,y,z (surface=5006500 points x-y,d e p t h = 3 0 p o i n t sz)
which was further processed in order to obtain a final map of cell
distribution, defined as
map~log 1z
maxzMzszMz  M Mz
3
  
ð1Þ
where maxzM =maximum intensity value, szM =standard devia-
tion, and  M Mz =mean intensity, all computed along the z dimension of
M a n dn o r m a l i s e dt ot h e i rm a x i m u mv a l u e .T h el o g a r i t h mw a su s e d
to transform the intensity distribution so that background values were
Normally distributed. In order to compensate for batch-to-batch
variability, all maps obtained in a given field of view were normalised
by scaling their values in the range [0, 1].
Cell confluency algorithm
For all cell distribution maps from one Z-stack, symmetrical 2D
intensity co-occurence histograms C(Dx, Dy) were computed using
pairs of points separated by Dx=10 pixels (Dy=0). The distance
Dx was chosen so the likelihood of co-occurrence of background
pairs of pixels (from uniform areas) was significantly increased
compared to the more variable cell signals. Median values were
computed down the columns of C and all profiles from the same
batch (i.e. Z-stack) were averaged to smooth low frequency cell
signal co-occurrences whilst emphasizing the distribution of
background noise co-occurrences. The resulting profile PC was
smoothed with a 561 averaging kernel, and its absolute first
derivative computed as DPc. This curve had high magnitude in
regions of large fluctuations of Pc (allegedly background) and low
magnitude elsewhere (in the largest proportion of the dynamic
range representing cell signal). The threshold T for separating
background from signal values was defined as the last intensity for
which DPc was higher than the value mean(DPc)+1.966SD(DPc).
The final confluence measurement was calculated as the
percentage of signal area in a map, corrected for spherical
distortion induced by mapping the 2D surface of a 3D spherical
microcarrier onto a 2D plane.
Validation of confluence measurements
Artificial in silico microcarriers and cells were modelled to
quantify the performance of the segmentation algorithm, estimate
the true confluence of the cells in 3D, and assign an error to the
estimated true confluence. Artificial maps were created by random
addition of N 2D Gaussian kernels of various sizes and magnitudes:
X
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where AN is the magnitude of the N
th kernel, the variables x are
spatial coordinates along dimensions 1 and 2, m are positions of the
kernel peaks, s are their standard deviations,
z:
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is the correlation of x1 and x2 and n1,2 is the covariance. The
variable number of kernels allowed the generation of maps with
any confluence in the range 0–100%. Each synthetic map was
projected onto the surface of a 3D sphere. This three-dimensional
volume was sampled at a resolution comparable to confocal
microscope imaging. Points located between the surfaces of the
artificial microcarrier and the 3D maps were labelled as cell
objects. Segmented cell regions in artificial datasets were
convoluted with a Gaussian point spread function (PSF) with
standard deviation estimated from real confocal datasets. This
processed blurred the true signal most predominantly along the Z
axis. Finally, noise was added to the whole data volume. The
modelled noise had a distribution identical to the noise measured
from real confocal datasets.
Principal Component Analysis
The intensity co-occurrence matrix of the cell distribution maps
was used for texture quantification, by computing contrast,
correlation, energy and homogeneity [34,35]. These measure-
ments were subjected to principal component analysis (PCA) and
the first two principal components (PC) were used to monitor the
morphology of the cell distributions quantitatively over time. The
distribution of points in the PC space provided an instant non-
subjective representation of the cell morphologies at the surface of
the microcarriers. The most representative maps were identified as
those located closest to the centre of the PC distributions.
Results
Generation of cell distribution maps
Measuring the properties of cells adhered to the surface of
microcarrier beads is more complex than performing the measure-
ments in standard 2D culture due to the spatial distribution of the
cells aroundthebead.To address this we developed animage analysis
approach to process the 3D data obtained using confocal microscopy
to produce 2D ‘‘cell distribution maps’’ which could be used for
automated measurements of cell number, confluency and morphol-
ogy. A summary of the process is shown in Figure 1. Confocal
microscopy images of cells adhered to the surface of microcarriers
were processed by applying a Hough transform-based algorithm to
locate the microcarriers in the X-Y plane (Fig. 1A, number circles).
This commonly used image analysis tool allowed individual
microcarriers to be identified and the image datasets for each
microcarrier to be isolated and processed independently (Fig. 1B).
The confocal image stack for each individual microcarrier were then
extracted into a sub-volume and processed along the Z-axistoidentify
the top and bottom coordinates of the microcarrier (Fig. 1C), which
in combination with the X-Y data extracted previously allowed the
whole microcarrier surface to be identified. Next a grid was mapped
onto the surface of the microcarrier and the fluorescent intensity was
measured in each grid at 30 points orthogonal to the microcarrier
surface (Fig. 1D). The intensity measurements encompassed the area
above and below the microcarrier surfaceto ensure they captured the
volume of the cells adhered to the microcarriers. The gridded
fluorescent intensity measurements were then unwrapped from the
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to create a ‘cell distribution map’ showing the location and
morphology of the cells (Fig. 1E). This 2D map of the distribution
of the cells on the 3D microsphere could then be used for analysis of
cell number and confluency.
Measurement of cell number and confluency
Development of a method for automated analysis of cell
confluency and its link to cell number was initially established using
cells in 2D monolayer culture adhered to the surface of 2 mm
2
gridded slides (Fig. 2A). Cells seeded at densities ranging from 200–
1200 cells/grid were imaged and the cell areas were segmented using
manual thresholding, which identified the cells by their fluorescence
intensity compared to the background (Fig. 2B). The total surface
area covered by the cells within the grids was measured and
compared to manual cell number counts for each image and were
shown to have a linear relationship across the cell density range
(Fig. 2C). To establish if the same principle could be applied to cell
attached to microcarriers,a ‘cell confluency algorithm’ was developed
which could automatically segment cells using the same thresholding
process applied to the cells in the 2D monolayer culture. A series of
cell distribution maps were then generated from cells attached to
beads at densities from ,5 cells/bead (low confluency) to .30 cells/
bead (high confluency) (Fig. 2D–E). Comparison of confluency
measurements generated using the ‘cell confluency algorithm’ with
manual cell counts from each bead also showed a linear relationship
across the seeding density range (Figure 2F).
Validation of the cell distribution mapping approach
To demonstrate that the procedure of creating cell distribution
maps provides an accurate means to measure the confluency and
number of cell adhered to microcarriers using the cell confluency
algorithm the process was validated in two stages.
In the first stage of the validation process cells were seeded onto
microcarrier at 4 different densities. Samples from each density
range were then either fluorescently labelled and imaged to create
cell distribution maps or lysed to extract DNA for cell number
analysis using the commercially available Cyquant assay. Cell
numbers attained using the two processes were then compared
(Fig. 3). This analysis showed a strong linear relationship
(R
2=0.974) between the two measurements indicating that the
mapping process provides good platform for quantifying cell
number.
In the second stage of the validation process the cell confluency
algorithm was used to measure the confluency of in silico generated
cell distribution maps. This process allows a direct comparison of
the confluency measurements generated by the algorithm against
the known ‘ground truth’ confluency measurements from the in
silico maps. The process also allows controlled levels of noise and
point spread function (PSF) to be added to the artificial maps to
measure how these imaging artefacts bias the confluency
measurements. The process-map for the development of the in
silico cell distribution maps is shown in Fig. 4A. Over 1600 in silico
ground truth maps of cells distributions at different confluency
levels were generated and projected onto spherical surfaces with
the same geometric properties as the microcarrier beads. Fig. 4B
shows a comparison of ‘real’ cells adhered to the surface of the
microcarriers at 3 different densities (Fig. 4B ‘‘1’’) compared to the
in silico generated images of cells on beads at comparable densities
(Fig. 4B ‘‘2’’) and the 3D renderings of the in silico cells on beads
(Fig. 4B ‘‘3’’).
The accuracy of the cell confluency algorithm was initially
validated on the in silico cell distribution maps in the absence of
Figure 1. Mapping the distribution of HDF cells on the surface of microcarrier beads. (A) Maximum intensity projection from confocal
image Z-stack with microcarriers identified by Hough transform (circles). (B) Extraction of sub-volume from Z-stack containing 3D fluorescence
associated with a single microcarrier. (C) Top and side projection images calculated from sub-volume used to locate X-Y-Z coordinates of microcarrier
(dashed circles and arrows). (D) Iterative fluorescence intensity measurements in the vicinity of the microcarrier surface (sphere) using 30 sampling
spherical grids (horizontal planes in magnified sampling volume, extended to the whole microcarrier surface). (E) Cell distribution map (bottom)
computed from unwrapped stack of sampling grids (top, Mx,y,z).
doi:10.1371/journal.pone.0026104.g001
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cell distribution map (Fig. 5A ‘‘1’’) and the comparable cell
identification achieved using the cell confluency algorithm (Fig. 5A
‘‘2’’). Comparison of the confluency measurements achieved using
the cell confluency algorithm against the known ground truth
measurements from in silico maps with 0–100% cell confluency
(Fig. 5B) showed a linear response between the two measurements
(R
2=0.982, slope=0.92 for linear regression), indicating that in
‘clean’ images the algorithm is measuring cell confluency levels
with a good degree of accuracy.
To further validate the mapping process, the in silico ground
truth cell distribution maps underwent convolution with PSF and
addition of noise to closely mimic the images obtained in real
datasets. Fig. 5C shows the identification of cells for confluency
measurements on an in silico ground truth map using optimal
thresholding (Fig. 5C ‘‘1’’) and the comparable cell identification
using the cell confluency algorithm (Fig. 5C ‘‘2’’). Comparison of
these measurements from 0–100% confluency (Fig. 5D) showed a
strong non-linear response between actual and measured conflu-
ences. This bias was predominantly a consequence of the PSF,
which could be modelled (Fig. 5D black line) and corrected.
Comparing the bias-corrected confluency measurements to the
original in silico ground truth measurements (Fig. 5E) restored the
linearity between the two measurements (R
2=0.96). Residual
analysis was used to calculate that the error associated with
measurements of confluency using the cell confluency algorithm is
approximately 10% (Fig. 5F).
Application of image analysis for bioreactor monitoring
To demonstrate that the cell distribution mapping approach
could be used for measuring the confluency of live cells grown
under different manufacturing conditions human dermal fibro-
blasts were grown at 2 seeding densities on the surface of
microcarriers (5 or 10 cells per microcarrier) in stirred tank
bioreactors for 13 days. Samples taken from the bioreactors at
various time points were imaged, used to create cell distribution
maps and analysed for cell number and confluency. The texture
parameters of the maps were also subjected to principal
component analysis (PCA) and the first two principal components
(PC) were used to quantitatively monitor change in morphology of
the cell distributions over time (Fig. 6). The distribution of points
in the PC space provides a non-subjective representation of the cell
morphologies at the surface of all of the sampled microcarriers
(Fig. 6A). Microcarriers containing the highest cell densities are
clustered on the left of the PC space (Fig. 6B), those containing the
lowest cell number being clustered on the right (Fig. 6C) and the
Figure 2. Comparison of confluency and cell number measurements in 2D and 3D culture. (A) 2D monolayer culture of fluorescently
labelled HDF cells seeded on 2 mm
2 gridded slides at three different seeding densities. (B) Cell segmentation of the images using manual
thresholding to identify the individual cells. (C) Graph showing the linear relationship between cell confluency and cell number in 2D culture. (D) 3D
microcarriers seeded with fluorescently labelled HDF cells at three different densities. Dashed lines show circumference of the microcarrier beads. (E)
Segmented cell distribution maps processed using the cell confluency algorithm. (F) Graph showing the linear relationship between cell number and
confluency for cells grown on microcarrier beads and analysed using the cell confluency algorithm.
doi:10.1371/journal.pone.0026104.g002
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closest to the centre of the PC distributions (Fig. 6D).
The most representative maps of cell growth identified from the
PCA at different time points for microcarriers seeded at the two
different densities are shown in Fig. 7. Uniform seeding of the cells
onto the microcarrier was achieved after 3 hours of bioreactor
culture for both seeding densities with an average of 4.2 cells per
bead for the lower seeding density and 11.2 cells per bead for the
higher density. At the lower seeding density, the cells spread more
quickly onto the microcarriers, although morphologically they
were not different to cells at the higher density. After 3 days
however, the majority of cells became fragmented, leaving on
average 2 to 3 cells per bead. Some expansion was achieved by the
end of the first week, although significant bead-to-bead variability
was still observed and this eventually led to majority of cells dying
within the bioreactor and very few beads containing viable cells by
day 13. In comparison, the microcarriers which were seeded at the
higher density had numerous cell colonies or clusters within 3 days
of culture, which subsequently sustained cell proliferation to the
point where the majority of the surface of the microcarriers was
covered by cells after 13 days in the bioreactor.
Quantitative analysis of bioreactor cultures
To quantitatively analyse the growth of cells in the bioreactor
culture a series of cell distribution maps were created from samples
taken over the 13 day growth period. These maps were then
analysed using the cell confluency algorithm. (Fig. 8). This analysis
shows that cells seeded onto microcarriers at a density of 10 cells
Figure 3. Comparison of cell number measurments. Graph to the
show the linear relationship between cell number measurements
obtained using the cell distribution mapping process and the
commercial Cyquant assay.
doi:10.1371/journal.pone.0026104.g003
Figure 4. Validation of distribution mapping process with in silico modelling of cells adhered to microcarrier beads. (A) Flow diagram
for in silico modelling (top compartment) and validation of confluence measurement (bottom compartment). (B) 1- Maximum intensity top projection
confocal images of real HDF cells adhered to microcarrier beads. 2 – Synthetic maximum intensity top projections of cells distributions around
microcarrier beads generated by in silico modelling. 3 – 3D rendering of the synthetic cell distribution in B2 to show cell localisation and
comparability to real image data.
doi:10.1371/journal.pone.0026104.g004
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PLoS ONE | www.plosone.org 6 October 2011 | Volume 6 | Issue 10 | e26104Figure 5. Validation of confluency measurements using cell distribution mapping. (A) 1 - Ground truth synthetic cell distribution map
generated in absence of noise or PSF. 2 – cell confluency map generated from the synthetic data using the distribution map image processing
algorithm. (B) Comparison of synthetic ground truth confluence versus measured confluence. The ground truth confluence is known before artificial
3D modelling (from A1) whereas the measured confluence is calculated from the map obtained after processing of the 3D model (from A2). White
line=power model fit, black lines are 95% confidence intervals. (C) 1 - Optimal thresholding (white lines) of cell distribution map shown in A1 after
convolution of the 3D model with PSF and the addition of noise. 2- Cell confluency analysis of image B1 generated using the cell distribution
mapping algorithm. (D) Comparison of true confluence (from ground truth data) with confluence measured by the cell distribution mapping
algorithm. Over-estimation from the proposed method is evident from the shape of the data distribution. However this bias can be accurately
modelled (black curve). (E) True confluence (from ground truth maps) versus measured confluence calculated from D (y axis) and the fitted model (D,
black curve). Estimated confluence through bias compensation restores the expected linearity between true and estimated confluences (R
2=0.96).
Bold and dashed lines represent linear fit 695% confidence interval. (F) Error estimation by residual analysis. Residual values are obtained by
subtracting linear fit values from estimated confluences in E. Dashed lines represent 695% confidence interval.
doi:10.1371/journal.pone.0026104.g005
Monitoring Cell Growth in 3D Bioreactor Culture
PLoS ONE | www.plosone.org 7 October 2011 | Volume 6 | Issue 10 | e26104per bead (Fig. 8A black circles) undergo an initial lag in growth
over the first 3 days of culture before entering a linear growth
phase and reaching almost full confluency after 7 days. In
comparison, cells seeded at the lower density (Fig. 8A open boxes)
underwent a decrease in confluency over the first 3 days of culture
before entering a proliferative state up to day 7 and then dying
within the bioreactor, such that even after 11 days of culture the
average confluency of cells on the microcarriers was only ,8%.
Analysis of the confluency variability over time, defined as
standard deviation divided by the median (Fig. 8B), showed that
the initial variability in the confluency levels for the two seeding
densities were almost the same (,40%). However, as cells were
grown in the bioreactor over 13 days the variability in bead-to-
bead confluency levels for the cells seeded at the lower density
significantly increased to .150% (Fig. 8B open squares) while the
variability in bead confluency levels for the cells at the higher
density slowly decreased to ,10%. This low inter-bead variability
at the higher density demonstrates that cell growth is progressing
evenly throughout the bioreactor culture.
In addition to confluency measurements, cell morphology could
also be quantified using PCA to give a measure of cell health
within the bioreactor environment (Fig. 8C–D). This analysis
shows that cells seeded at the higher densities initially have a larger
cell to cell morphological variability (,22%) than cells at the lower
seeding density (,5%). However, morphological variability in the
higher density culture then decreases over the first 7 days as the cells
are proliferating eventually reaching a plateau as the cells become
fully confluent (,5%). In comparison morphological variability in
the lower seeding density culture is stable for the first 7 days even
though the cells are proliferating. As the cells begin to die after 7
days of culture the morphological variability dramatically increases
(,28%) indicating an unhealthy culture.
PCA can also be used to graphically compare the morphologies
between low and high seeding densities (Fig. 8E–F). At the time of
seeding the cells onto the beads the PCA analysis shows that the
morphology of the cells at the higher density forms a tight cluster
on the right-hand side of the PCA space (Fig. 8E black line) while
the cells seeded at the lower density form a less compact but
overlapping cluster (Fig. 8E dashed line). By 7 days of culture
which correspond to the time immediately before the cells at the
lower seeding density will begin to die, the PCA analysis shows a
clear divergence in cell morphologies between the two culture
Figure 6. Principal Component Analysis (PCA) of the cell distribution maps. (A) Texture measurements from microcarrier seeded with 10
cells per bead and incubated for 2.5 hours were subjected to PCA and 1
st and 2
nd principal components were plotted. The PCA scatter plot provides a
snapshot graphical representation of the distribution of cell morphologies. (B) Cell distribution maps taken from the left of the PCA space have the
highest cell confluency. (C) Distribution maps from the right of the PCA have the lowest cell confluency. (D) The most representative cell distribution
maps for the analysis are located in the centre of the PCA space.
doi:10.1371/journal.pone.0026104.g006
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clustered in the same location with the PCA space (Fig. 8F black
line). However, the lower seeding density cells have strongly shifted
with the PCA space forming a large distinct cluster on the left
hand side (Fig. 8F dashed line), which in this case indicates a cell
morphology associated with an unhealthy bioreactor culture.
Discussion
As regenerative medicine products transition from the labora-
tory into clinical application the requirement to produce cells in
commercially viable quantities is driving the use of bioreactor
based manufacturing [1]. This approach presents a number
challenges particularly as many of the cell models used for
therapeutic application require adherence to a solid substrate on
which to grow. In turn, this makes it difficult to perform biological
measurements directly on the cells to ensure optimal growth and
allow quality control of the production process [31].
In standard 2D cell culture, batch quality control throughout
the cell expansion process generally includes subjective measure-
ments of cell confluency and cell morphology as well as direct
measurements of cell number. However, there are currently no
methods to measure all these parameters simultaneously in 3D
bioreactor culture systems. Instead, bioreactor measurements tend
to analyse a single property such as cell number. This provides
only limited information and does not provide a quantitative
representation of important parameters such as the homogeneity
of the cell population or the morphology and distribution of the
cells. In this paper, we have described a versatile yet powerful
method to achieve multiplexed measurements of cell number,
confluency and morphology in 3D bioreactor cultures. This is
achieved by processing the data generated from confocal
microscopy imaging to create a 2D map of the distribution of
the cells on their 3D growth substrate while maintaining the cell
morphology information. The cell distribution maps can then be
used for automated analysis of cell number and confluency using
routine segmentation and thresholding approaches. This method
was designed to incorporate commonly used procedures such as
bioreactor sampling, fluorescent cell labelling and microscopy
imaging with a series of validated algorithms which are operated
using the commercially available Matlab platform in order to
allow the procedure to be easily used in other laboratories. The
analysis time for this method is comparable to cell counting
methods employed in standard 2D culture which, depending on
the assay used, can range from a few minutes (e.g. trypan blue
assay) to several hours (e.g. MTT assay). In this study, the
fluorescent Calcein-AM labelling of viable cells has an assay time
of less than 30 minutes, allowing the cells to be labelled without
affecting viability and morphology. On a typical confocal imaging
platform, another 30 minutes are necessary to acquire the raw
image datasets to constitute a statistically relevant sample. Once
the raw data is acquired, image processing and analysis can be
performed in approximately 30 minutes giving a total assay time
of about 1.5 hours. However, this could be improved through
parallel processing (simultaneous to data acquisition), which would
potentially ensure that the whole process, from cell labelling to
quantitative analysis, would take just 60 minutes. The image
processing and analysis software has also been thoroughly
Figure 7. Cell distribution maps to visualise changes in cell confluency in response to cell seeding density. Microcarriers were seeded
with either 5 cells per bead (left column) or 10 cells per bead (right column) and the most representative cell distribution maps from the centre of the
PCA space were used to visualise difference in cell confluency over an 11 day culture period.
doi:10.1371/journal.pone.0026104.g007
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real datasets and has been shown to have an accuracy of 90%
which is comparable to standard cell number assays such as MTT.
The use of cells in therapeutic applications requires stringent
monitoringduringthemanufactureprocess.This makes itimportant
to be able to link measurements such as cell number to the health
and quality of the cells during processing. The approach undertaken
in this study presents a number of advantages for use in quality
control procedures. Firstly, only small samples are required to obtain
statistically relevant data, in this study a 5 ml sample was used for
labelling and microscopy but, dependant on the concentration of
microcarriers in the bioreactor, this could be reduced significantly.
For example, the bead concentration presented here was approx-
imately 52,000 beads/ml which would mean that .200 beads could
be analysed from a bioreactor sample as small as 5 ml. This small
sampling size is particularly attractive for the manufacture of cell
therapyproductswhereasignificantproportionoftheproductcostis
tied up in the manufacture of the cells [36]. The use of this imaging
approach with fluorescent dyes such as Calcein-AM also offers the
potential for the samples to be fixed post-labelling and stored at 4uC
for several weeks permitting subsequent detailed analysis if, for
example, end-of-process cells are not of sufficient quality. Storage of
raw images and processed maps also offers the possibility of data re-
analysis, currently not achievable when only a simple cell count is
Figure 8. The use of PCA to quantitatively measure cell number, morphology and confluency during cell manufacture. (A) changes in
cell confluency over 11 days in bioreactor culture for HDF cells seeded onto microcarriers at a density of 10 cells per bead (black squares) or 5 cells per
bead (open squares). Fitted curves=median values, error bars=16
th–84
th percentiles (percentiles are used to accommodate skewed distributions. If
the data were Normally distributed, the 16
th–84
th percentiles would correspond to 6 1SD). (B) Measurement of bead to bead variability in cell
confluency during the 11 day manufacture procedure for cells seeded onto microcarriers at a density of 10 cells per bead (black squares) or 5 cells per
bead (open squares). (C) Analysis of cell morphology using the 1
st PC shows that microcarriers seeded at 10 cells per bead (black squares) maintain a
stable morphology compared to microcarrier seeded at 5 cells per bead (open squares). (D) Analysis of the bead to bead variability in cell
morphology for microcarrier seeded at 10 cells per bead (black squares) and 5 cells per bead (open squares). (E–F) The use of PCA to show differences
in morphological distribution of cells seeded onto microcarrier at 10 cells per bead (black squares) or 5 cells per bead (open squares) after 2.5 hours
(E) and 7 days (F) in bioreactor culture.
doi:10.1371/journal.pone.0026104.g008
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the analysis of the data itself is fully quantitative and does not rely
upon subjective assessment by trained staff, thereby allowing
traceability throughout the manufacture process.
The transition from standard cell culture to bioreactor based
manufacture is driven by practical issues associated with handling
large cell volumes and economic decisions regarding product cost
reduction. For human cells used in cell therapy products, which
are typically slow to expand in culture, it is important to have
methods in place which can be used to reduce manufacture costs
by optimising processes and identifying problems quickly [37].
The cell distribution mapping approach described here, in
combination with quantitative analysis of cell number and
confluency go someway to helping achieve this. In this study we
show how cells seeded at an initial density of 10 cells per bead have
reached maximum confluency within 7 days of bioreactor culture,
while cells seeded at 5 cells per bead have only reached 44%
confluency during this time. Even though under these conditions
the lower seeding density cells eventually died, if they had a
maintained a linear proliferate rate it would have taken
approximately 7 more days of culture for them to reach full
confluency. Having this type of quantitative information to hand
can therefore be invaluable in helping inform the decisions making
processes about the economic trade of between initial seeding
densities and the length of manufacture time.
Image based morphological measurements of individual cells in
2D systems is the principle behind powerful platform technologies
such as high content screening (HCS). These technologies are
being used to ‘industrialise’ cell analysis particularly in drug
discovery research by combining automation, sample preparation,
image acquisition, processing and analysis to permit subtle changes
in cell morphology be measured in great detail [38–40]. The
principals of HCS are equally applicable for monitoring the health
of cells during bioreactor manufacture but have not yet been
adapted for this purpose. With therapeutic cell lines, changes in
cell morphology can be indicative of a problem with the
manufacture process which in turn may have detrimental effects
on the quality of the cells (e.g. reduced expansion by increased
contact inhibition or spontaneous differentiation of stem and
progenitor cells). In this study we used well described texture
measurements [35,41] to quantify and classify cell morphology on
the microcarriers. Under different manufacturing conditions, such
as cell seeding density, PCA clearly identified two morphologically
distinct distributions amongst the cell populations. One of which
does not lead to cell expansion. This approach could therefore be
used to identify sub-optimal cultures rapidly following seeding
preventing wasted manufacturing time. The mapping process
described in this study also considerably compressed the
information contained in the original 3D image volumes, in this
case reducing the size of the dataset for a statistically relevant
analysis by a factor of 43. However, under optimal conditions this
compression factor could be increased to .200 without significant
loss of information. This dramatically increases the processing
speed for image data analysis overcoming some of the data
management bottlenecks that have been encountered with HCS
[42]. Furthermore, as cell technologies change, and in particular
as 3D culture technologies become incorporated into drug
screening programmes, the type of analysis system described in
this paper could also support the transition of HCS into high-
throughput 3D drug development cell models [43].
Although the approach presented in this study has been shown
to be robust and reliable, there is potential for improving the
image analysis software by incorporating deconvolution algorithms
or introducing different texture metrics that are specific for a
particular cell type. This would be useful for cell therapy products
based on stem cells or other progenitor populations which
incorporate a differentiation step following cell expansion. A good
example of this would be monitoring the production of neural cells
for the clinical treatment of neurodegenerative diseases. It has
been shown that morphological measurements can be used to
assess the differentiation of stem cells along a neuronal lineage
identifying, for example, the development of neurite outgrowths
typical of developing neurons [44]. This could also be combined
with fluorescent immunocytochemistry to incorporate morphology
measurements alongside cell specific markers such as b-III tubulin,
GFAP and O4 to identify developing subpopulations of neurons,
astrocytes and oligodendrocytes during the manufacture process.
In conclusion, as cell manufacture transitions from standard
culture into bioreactor based processing the tools to monitor cell
growth and measure cell quality need to be in place. The cell
distribution mapping approach described in this paper goes some
way to achieving this by providing a system for the unbiased
multiplexed measurement of cell number, confluency and
morphology. This offers distinct advantages over current methods
of analysis, which typically measure a single parameter, by
providing a more comprehensive evaluation of cell growth and
allowing bioreactor culture performance to be optimised. In
addition the minimal number of manual and sample handling
steps combined with fast automated analysis would facilitate the
use of this type of analytical approach within a cell manufacture
facility and could help in the transition towards bioreactor based
manufacture for clinical grade cells.
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